PEAK6 Investments’s Astrana Health ASTH Stock Holding History

PEAK6 Investments’s Portfolio ASTH Stock Details ASTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-899	Closed	-$66K	–	6060
2021 Q4	$66K	Buy	+899	New	+$73.9K	﹤0.01%	4533

Other funds holding ASTH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

OAM

Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

PEAK6 Investments's ASTH Position: Q1 2022 in Review

PEAK6 Investments sold out of Astrana Health (ASTH) in Q1 2022, closing a stake of 899 shares — an estimated $66K sold.

PEAK6 Investments first reported a position in ASTH in Q4 2021 and held it in 1 quarter. The position peaked at $66K in Q4 2021. 139 funds tracked by Wall St. Rank hold ASTH as of Q1 2022.

PEAK6 Investments reported no remaining Astrana Health position as of Q1 2022 after selling out during the quarter.
PEAK6 Investments sold 899 Astrana Health shares in Q1 2022, an estimated $66K.
PEAK6 Investments first reported a position in Astrana Health in Q4 2021 and held it in 1 quarter.
PEAK6 Investments's Astrana Health position peaked at $66K in Q4 2021.
139 funds tracked by Wall St. Rank held Astrana Health as of Q1 2022.

Based on PEAK6 Investments's 13F filing for Q1 2022, filed 13 May 2022.